tiprankstipranks
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

KalVista Pharmaceuticals (KALV) Balance Sheet

357 Followers

KalVista Pharmaceuticals Balance Sheet

KalVista Pharmaceuticals's total assets for Q4 2024 were $235.37M, an increase of 106.52% from the previous quarter. KALV total liabilities were $28.82M for the fiscal quarter, a 13.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Apr 24Apr 23Apr 22Apr 21Apr 20
Total Assets
$ 235.37M$ 183.20M$ 203.88M$ 272.01M$ 92.53M
Total Liabilities
$ 28.82M$ 22.18M$ 18.79M$ 14.82M$ 8.78M
Total Equity Gross Minority
$ 206.61M$ 161.01M$ 185.09M$ 257.19M$ 83.75M
Total Capitalization
$ 212.62M$ 168.17M$ 185.09M$ 257.19M$ 83.75M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 5.91M$ 1.65M
Currency in USD

KalVista Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis